No approved vaccine or therapeutic exists for this strain
In the remote eastern reaches of the Democratic Republic of Congo, a rare and poorly understood variant of Ebola has emerged in conditions almost designed to defeat containment — armed conflict, fractured infrastructure, and the absence of any approved vaccine or treatment. The World Health Organisation has declared a public health emergency of international concern, as over 300 suspected cases and 88 deaths mark only the third known appearance of the Bundibugyo strain since surveillance began half a century ago. Congo carries deep institutional memory of Ebola, yet memory alone cannot substitute for medicine, and the world is now in a race between the virus's movement and science's capacity to respond.
- A rare Ebola variant with no approved vaccine or treatment is spreading across Ituri province and beyond, reaching Congo's capital Kinshasa and the major eastern city of Goma within days of confirmation.
- Over 300 suspected cases and 88 deaths have been recorded across Congo and Uganda, with the Africa CDC director-general publicly admitting he is in 'panic mode' over the shortage of medicines.
- Armed groups have carried out 44 attacks on healthcare facilities since January 2025 alone, making it dangerous for health workers to reach patients in the very communities where the outbreak is most acute.
- Congo is opening three dedicated treatment centres in Ituri while the WHO deploys 35 experts and seven tonnes of emergency supplies — buying time for candidate therapeutics expected within weeks.
- Rwanda has closed its land border with Congo, the US has issued travel advisories, and international coordination is intensifying, but the window to prevent wider regional spread is narrowing fast.
The Democratic Republic of Congo is confronting an Ebola outbreak unlike any it has faced before — not because the disease is unfamiliar, but because this particular strain, Bundibugyo, has no approved vaccine or treatment, and it is spreading through one of the country's most volatile and inaccessible regions. Health Minister Samuel Roger Kamba announced plans to open three treatment centres in Bunia, the capital of Ituri province, as hospitals already strained by existing patients began absorbing a growing caseload.
The World Health Organisation declared the outbreak a public health emergency of international concern after more than 300 suspected cases and 88 deaths were recorded across Congo, with two additional deaths in neighbouring Uganda. Cases had already reached Kinshasa and Goma, suggesting the virus was moving well beyond its point of origin in Mongwalu, a busy mining area where population movement is constant.
Bundibugyo has appeared only twice before: in Uganda in 2007-2008, and in Congo's Isiro district in 2012. Both outbreaks were contained, but neither unfolded in conditions as severe as those now facing Ituri. Armed groups have killed dozens, displaced thousands, and attacked healthcare facilities at a rate of nearly one incident per day since the start of 2025. The WHO warned that insecurity and population movement would accelerate spread and undermine containment efforts.
The international response moved quickly — 35 WHO experts, seven tonnes of supplies, US travel advisories, and a closed Rwandan border — but the gap between need and available tools remained stark. The Africa CDC's director-general described a critical shortage of medicines, with candidate treatments still weeks away. Congo's strategy, for now, is to expand capacity, isolate cases, and support patients through the infection while waiting for science to deliver what does not yet exist. Whether that holds depends as much on the behaviour of armed groups and frightened communities as it does on the health system itself.
The Democratic Republic of Congo is racing to build capacity for a disease it has faced before but never quite like this. On Sunday, the country's health minister Samuel Roger Kamba stood in Bunia, the capital of Ituri province in the east, and announced plans to open three dedicated treatment centres. The urgency was unmistakable. Hospitals in the region were already straining under the weight of existing patients, and now they faced an outbreak of the Bundibugyo virus—a rare variant of Ebola for which no approved vaccine or therapeutic treatment exists.
The World Health Organisation had just declared the situation a public health emergency of international concern, a designation reserved for events that signal serious risk and demand coordinated global response. The numbers behind that declaration were stark: more than 300 suspected cases and 88 deaths across Congo, with two additional deaths reported in neighbouring Uganda. Cases had spread beyond the outbreak's epicentre in Ituri, reaching Kinshasa, the capital, and Goma, the country's largest eastern city. By Friday, when the outbreak was officially confirmed, the virus was already moving.
Bundibugyo is not new to the region, but it is rare. Since 1976, when Ebola surveillance began in Central Africa, the virus has sparked more than 20 outbreaks across Congo and Uganda. Yet Bundibugyo has appeared only twice before: in a 2007-2008 outbreak in Uganda's Bundibugyo district that infected 149 people and killed 37, and again in 2012 in Isiro, Congo, where 57 cases and 29 deaths were recorded. This third emergence presented a puzzle for health authorities. The disease itself—fever, headache, muscle pain, weakness, diarrhoea, vomiting, stomach pain, and unexplained bleeding—was recognizable. But the absence of proven medical countermeasures meant treatment would focus on managing symptoms and supporting patients through the infection, a strategy that had worked in past outbreaks but offered no guarantee.
Congo's experience with Ebola is extensive, and that experience mattered. Yet the current outbreak was unfolding in conditions that made response exponentially harder. Ituri province sits in Congo's remote east, more than 1,000 kilometres from Kinshasa, connected by poor roads and limited infrastructure. More critically, the region was already in crisis. Armed groups had killed dozens and displaced thousands in the past year. Since January 2025 alone, there had been 44 attacks on healthcare facilities across Congo and 742 incidents targeting humanitarian workers. The WHO warned that intense population movement, insecurity, and the presence of armed actors would accelerate spread and complicate containment. Health systems were already weak; services were already insufficient. The first confirmed cases emerged in Mongwalu, a high-traffic mining area where people moved constantly.
The international response mobilized quickly. The WHO deployed a team of 35 experts to Bunia along with seven tonnes of emergency medical supplies and equipment. The US Centers for Disease Control issued travel advisories, urging Americans in Congo and Uganda to avoid people showing symptoms. At least six Americans had been exposed to the virus, though US health officials characterized the risk to the broader American population as low. Rwanda closed its land border with Congo on Sunday. Yet even as resources arrived, the gap between need and availability was stark. Jean Kaseya, director-general of the Africa CDC, told Sky News he was in "panic mode" over the shortage of medicines and vaccines as deaths climbed. Some candidate treatments were expected within weeks, he said, but weeks could mean hundreds more cases.
Dr Gabriel Nsakala, a public health professor who had worked on previous Ebola responses in Congo, acknowledged the country's deep experience but also the complication posed by this particular strain. Congo knew how to fight Ebola. What it did not know was whether the tools that had worked before would work now. The treatment centres being opened in Ituri represented Congo's answer: expand capacity, isolate cases, support patients, and buy time for international science to deliver the therapeutics that did not yet exist. Whether that would be enough depended on factors largely beyond the health system's control—on whether armed groups would allow health workers to move freely, on whether people would seek treatment rather than hide illness, on whether the virus would spread faster than the response could contain it.
Citações Notáveis
We are preparing to have treatment centres at all three sites in order to be able to expand our capabilities.— Samuel Roger Kamba, Congolese health minister
The outbreak is currently occurring in provinces marred by crisis, including insecurity, presence of armed actors or de facto authorities with large displacement, weak health systems and insufficient availability of services.— World Health Organisation
A Conversa do Hearth Outra perspectiva sobre a história
Why does it matter that this is the Bundibugyo variant specifically, rather than one of the other Ebola strains?
Because there are no approved vaccines or treatments for it. With other Ebola variants, you have options—monoclonal antibodies, vaccines that have been tested and proven. With Bundibugyo, you're essentially starting from scratch. You can only manage symptoms and hope the patient's immune system wins.
Congo has dealt with Ebola outbreaks before. Why is this one different?
Experience helps, but it doesn't solve the problem of armed conflict. The first cases appeared in a mining area where people move constantly. Armed groups control parts of Ituri. Healthcare workers have been attacked. You can't contain a disease if you can't reach patients, and you can't reach patients if the roads aren't safe.
The WHO called it a public health emergency of international concern. What does that actually trigger?
It's a signal that says this is serious, it could spread across borders, and it needs coordinated action from multiple countries and agencies. It opens funding channels, it mobilizes expertise, it gets attention. But it doesn't create vaccines or treatments overnight.
The director of the Africa CDC said he was in "panic mode." That's a striking phrase. What was he panicking about?
The mismatch between what's needed and what exists. Over 300 cases, 88 deaths, and no proven medical tools. He was saying: we can build treatment centres, we can isolate patients, but without therapeutics, we're limited in what we can actually do to save lives.
What happens in the next few weeks?
Candidate treatments are expected. If they work, they change everything. If they don't, or if they arrive too late, the outbreak could spread further into Uganda, into other provinces. The race is between the virus's speed and the speed of international response.